Literature DB >> 11212475

The prevalence of episodic pain in cancer: a survey of hospice patients on admission.

M Swanwick1, M Haworth, R F Lennard.   

Abstract

Pain that varies with time, referred to here as episodic pain, is a commonly encountered but under-investigated clinical problem. Previous studies of cancer patients have found that a significant proportion of their pains are episodic. To establish the prevalence and characteristics of episodic pains in hospice in-patients we assessed 245 consecutive admissions to four hospices in Yorkshire. The admitting doctor completed a questionnaire, detailing the characteristics of all pains experienced by the patient in the previous 24 h. Two hundred and forty-two questionnaires were entered into the study. One hundred and thirty-two patients reported pain in the preceding 24 h, of these 93% had at least one episodic pain. In total, 228 pains were described, of which 211 were episodic with a wide variation in their temporal characteristics, intensities and limitation. One hundred and fifty-two episodic pains had a precipitating factor; movement and weight bearing being the most frequent precipitants. One hundred and sixty-eight episodic pains had a relieving factor, medication improving 54%. Ninety-five pains were related to the malignancy and 47 to concurrent illness. The study confirms that episodic pain is extremely common in cancer patients referred for in-patient hospice care and highlights the need for further evaluation of its management.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11212475     DOI: 10.1191/026921601668030190

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  14 in total

1.  Diagnosis and management of breakthrough cancer pain: Have all the questions been resolved? A Delphi-based consensus assessment (DOIRON).

Authors:  J Porta-Sales; C Pérez; Y Escobar; V Martínez
Journal:  Clin Transl Oncol       Date:  2015-12-22       Impact factor: 3.405

2.  [Experiences of cancer patients with breakthrough pain and pharmacological treatments].

Authors:  L Bertram; S Stiel; F Elsner; L Radbruch; A Davies; F Nauck; B Alt-Epping
Journal:  Schmerz       Date:  2010-12       Impact factor: 1.107

3.  Understanding the Chameleonic Breakthrough Cancer Pain.

Authors:  Sebastiano Mercadante; Russell K Portenoy
Journal:  Drugs       Date:  2021-01-30       Impact factor: 9.546

Review 4.  Breakthrough pain and its treatment: critical review and recommendations of IOPS (Italian Oncologic Pain Survey) expert group.

Authors:  Sebastiano Mercadante; Paolo Marchetti; Arturo Cuomo; Massimo Mammucari; Augusto Caraceni
Journal:  Support Care Cancer       Date:  2015-10-05       Impact factor: 3.603

Review 5.  Breakthrough pain in elderly patients with cancer: treatment options.

Authors:  Sophie Pautex; Nicole Vogt-Ferrier; Gilbert B Zulian
Journal:  Drugs Aging       Date:  2014-06       Impact factor: 3.923

6.  Intermittent cancer pain: clinical importance and an updated cancer pain classification.

Authors:  Wael Lasheen; Declan Walsh; Nabeel Sarhill; Mellar Davis
Journal:  Am J Hosp Palliat Care       Date:  2009-12-14       Impact factor: 2.500

7.  Informal hospice caregiver pain management concerns: a qualitative study.

Authors:  Marjorie Kelley; George Demiris; Huong Nguyen; Debra P Oliver; Elaine Wittenberg-Lyles
Journal:  Palliat Med       Date:  2013-04-23       Impact factor: 4.762

8.  Pain reports by older hospice cancer patients and family caregivers: the role of cognitive functioning.

Authors:  Rebecca S Allen; William E Haley; Brent J Small; Susan C McMillan
Journal:  Gerontologist       Date:  2002-08

9.  Canadian recommendations for the management of breakthrough cancer pain.

Authors:  P Daeninck; B Gagnon; R Gallagher; J D Henderson; Y Shir; C Zimmermann; B Lapointe
Journal:  Curr Oncol       Date:  2016-04-13       Impact factor: 3.677

10.  Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background Pain.

Authors:  Sebastiano Mercadante; Augusto Caraceni; Francesco Masedu; Teresa Scipioni; Federica Aielli
Journal:  Oncologist       Date:  2019-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.